APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alcoholic Hepatiti Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Alcoholic Hepatiti Drug Industry Research Report 2026

22 December 2025122 pages

Choose your research edition.

Industry ResearchAlcoholic Hepatiti Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Alcoholic Hepatiti Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Alcoholic Hepatiti Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alcoholic Hepatiti Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alcoholic Hepatiti Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alcoholic Hepatiti Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Alcoholic Hepatiti Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Alcoholic Hepatiti Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Alcoholic Hepatiti Drug include Vital Therapies Inc, Verlyx Pharma Inc, Promethera Biosciences SA, Intercept Pharmaceuticals Inc, Immuron Ltd, GRI Bio Inc, Gilead Sciences Inc, Generon (Shanghai) Corp Ltd and Alfact Innovation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Alcoholic Hepatiti Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Alcoholic Hepatiti Drug Market by Company

Vital Therapies Inc

Verlyx Pharma Inc

Promethera Biosciences SA

Intercept Pharmaceuticals Inc

Immuron Ltd

GRI Bio Inc

Gilead Sciences Inc

Generon (Shanghai) Corp Ltd

Alfact Innovation

Alcoholic Hepatiti Drug Segment by Type

IMM-124E

HepaStem

GRI-0621

F-652

Others

Alcoholic Hepatiti Drug Segment by Application

Clinic

Hospital

Others

Alcoholic Hepatiti Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alcoholic Hepatiti Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alcoholic Hepatiti Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alcoholic Hepatiti Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Alcoholic Hepatiti Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Alcoholic Hepatiti Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Alcoholic Hepatiti Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Alcoholic Hepatiti Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Alcoholic Hepatiti Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Alcoholic Hepatiti Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Alcoholic Hepatiti Drug Revenue of Manufacturers (2021-2026) Table 9. Global Alcoholic Hepatiti Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Alcoholic Hepatiti Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Alcoholic Hepatiti Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Alcoholic Hepatiti Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Alcoholic Hepatiti Drug, Product Type & Application Table 14. Global Alcoholic Hepatiti Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Alcoholic Hepatiti Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Vital Therapies Inc Company Information Table 19. Vital Therapies Inc Business Overview Table 20. Vital Therapies Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio Table 22. Vital Therapies Inc Recent Developments Table 23. Verlyx Pharma Inc Company Information Table 24. Verlyx Pharma Inc Business Overview Table 25. Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio Table 27. Verlyx Pharma Inc Recent Developments Table 28. Promethera Biosciences SA Company Information Table 29. Promethera Biosciences SA Business Overview Table 30. Promethera Biosciences SA Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio Table 32. Promethera Biosciences SA Recent Developments Table 33. Intercept Pharmaceuticals Inc Company Information Table 34. Intercept Pharmaceuticals Inc Business Overview Table 35. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio Table 37. Intercept Pharmaceuticals Inc Recent Developments Table 38. Immuron Ltd Company Information Table 39. Immuron Ltd Business Overview Table 40. Immuron Ltd Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio Table 42. Immuron Ltd Recent Developments Table 43. GRI Bio Inc Company Information Table 44. GRI Bio Inc Business Overview Table 45. GRI Bio Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio Table 47. GRI Bio Inc Recent Developments Table 48. Gilead Sciences Inc Company Information Table 49. Gilead Sciences Inc Business Overview Table 50. Gilead Sciences Inc Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio Table 52. Gilead Sciences Inc Recent Developments Table 53. Generon (Shanghai) Corp Ltd Company Information Table 54. Generon (Shanghai) Corp Ltd Business Overview Table 55. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio Table 57. Generon (Shanghai) Corp Ltd Recent Developments Table 58. Alfact Innovation Company Information Table 59. Alfact Innovation Business Overview Table 60. Alfact Innovation Alcoholic Hepatiti Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio Table 62. Alfact Innovation Recent Developments Table 63. Global Alcoholic Hepatiti Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Alcoholic Hepatiti Drug Sales by Region (2021-2026) & (k units) Table 65. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2021-2026) Table 66. Global Alcoholic Hepatiti Drug Sales by Region (2027-2032) & (k units) Table 67. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2027-2032) Table 68. Global Alcoholic Hepatiti Drug Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2021-2026) Table 70. Global Alcoholic Hepatiti Drug Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2027-2032) Table 72. North America Alcoholic Hepatiti Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 74. North America Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 75. North America Alcoholic Hepatiti Drug Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Alcoholic Hepatiti Drug Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Alcoholic Hepatiti Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 79. Europe Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 80. Europe Alcoholic Hepatiti Drug Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Alcoholic Hepatiti Drug Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Alcoholic Hepatiti Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 84. Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 85. Asia Pacific Alcoholic Hepatiti Drug Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Alcoholic Hepatiti Drug Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Alcoholic Hepatiti Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 89. South America Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 90. South America Alcoholic Hepatiti Drug Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Alcoholic Hepatiti Drug Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 94. Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 95. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 98. Global Alcoholic Hepatiti Drug Sales by Type (2027-2032) & (k units) Table 99. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2026) Table 100. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2027-2032) Table 101. Global Alcoholic Hepatiti Drug Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Alcoholic Hepatiti Drug Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2026) Table 104. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2027-2032) Table 105. Global Alcoholic Hepatiti Drug Price by Type (2021-2026) & (US$/unit) Table 106. Global Alcoholic Hepatiti Drug Price by Type (2027-2032) & (US$/unit) Table 107. Global Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 108. Global Alcoholic Hepatiti Drug Sales by Application (2027-2032) & (k units) Table 109. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2026) Table 110. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2027-2032) Table 111. Global Alcoholic Hepatiti Drug Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Alcoholic Hepatiti Drug Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2026) Table 114. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2027-2032) Table 115. Global Alcoholic Hepatiti Drug Price by Application (2021-2026) & (US$/unit) Table 116. Global Alcoholic Hepatiti Drug Price by Application (2027-2032) & (US$/unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Alcoholic Hepatiti Drug Distributors List Table 120. Alcoholic Hepatiti Drug Customers List Table 121. Alcoholic Hepatiti Drug Industry Trends Table 122. Alcoholic Hepatiti Drug Industry Drivers Table 123. Alcoholic Hepatiti Drug Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Alcoholic Hepatiti Drug Product Image Figure 5. Global Alcoholic Hepatiti Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Alcoholic Hepatiti Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Alcoholic Hepatiti Drug Sales (2021-2032) & (k units) Figure 8. Global Alcoholic Hepatiti Drug Average Price (US$/unit) & (2021-2032) Figure 9. IMM-124E Product Image Figure 10. HepaStem Product Image Figure 11. GRI-0621 Product Image Figure 12. F-652 Product Image Figure 13. Others Product Image Figure 14. Clinic Product Image Figure 15. Hospital Product Image Figure 16. Others Product Image Figure 17. Global Alcoholic Hepatiti Drug Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Alcoholic Hepatiti Drug, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Alcoholic Hepatiti Drug Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Alcoholic Hepatiti Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Alcoholic Hepatiti Drug Sales by Region in 2025 Figure 23. Global Alcoholic Hepatiti Drug Revenue by Region in 2025 Figure 24. North America Alcoholic Hepatiti Drug Market Size by Country in 2025 Figure 25. North America Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 26. North America Alcoholic Hepatiti Drug Revenue Market Share by Country (2021-2032) Figure 27. United States Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Alcoholic Hepatiti Drug Market Size by Country in 2025 Figure 31. Europe Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 32. Europe Alcoholic Hepatiti Drug Revenue Market Share by Country (2021-2032) Figure 33. Germany Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Alcoholic Hepatiti Drug Market Size by Country in 2025 Figure 44. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Alcoholic Hepatiti Drug Revenue Market Share by Country (2021-2032) Figure 46. China Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Alcoholic Hepatiti Drug Market Size by Country in 2025 Figure 55. South America Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 56. South America Alcoholic Hepatiti Drug Revenue Market Share by Country (2021-2032) Figure 57. Brazil Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country in 2025 Figure 61. Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Alcoholic Hepatiti Drug Revenue Market Share by Country (2021-2032) Figure 63. Egypt Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Alcoholic Hepatiti Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2032) Figure 69. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2032) Figure 70. Global Alcoholic Hepatiti Drug Price (US$/unit) by Type (2021-2032) Figure 71. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2032) Figure 72. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2032) Figure 73. Global Alcoholic Hepatiti Drug Price (US$/unit) by Application (2021-2032) Figure 74. Alcoholic Hepatiti Drug Value Chain Figure 75. Alcoholic Hepatiti Drug Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Alcoholic Hepatiti Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • IMM-124E
  • HepaStem
  • GRI-0621
  • F-652
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Vital Therapies Inc
  • Verlyx Pharma Inc
  • Promethera Biosciences SA
  • Intercept Pharmaceuticals Inc
  • Immuron Ltd
  • GRI Bio Inc
  • Gilead Sciences Inc
  • Generon (Shanghai) Corp Ltd
  • Alfact Innovation

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Alcoholic Hepatiti Drug Market Size (2021-2032)
  4. 2.2.2 Global Alcoholic Hepatiti Drug Sales (2021-2032)
  5. 2.2.3 Global Alcoholic Hepatiti Drug Market Average Price (2021-2032)
  6. 2.3 Alcoholic Hepatiti Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 IMM-124E
  9. 2.3.3 HepaStem
  10. 2.3.4 GRI-0621
  11. 2.3.5 F-652
  12. 2.3.6 Others
  13. 2.4 Alcoholic Hepatiti Drug by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Clinic
  16. 2.4.3 Hospital
  17. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Alcoholic Hepatiti Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Alcoholic Hepatiti Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Alcoholic Hepatiti Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Alcoholic Hepatiti Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Alcoholic Hepatiti Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Alcoholic Hepatiti Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Alcoholic Hepatiti Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Alcoholic Hepatiti Drug, Established Date
  9. 3.9 Global Alcoholic Hepatiti Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Vital Therapies Inc
  2. 4.1.1 Vital Therapies Inc Company Information
  3. 4.1.2 Vital Therapies Inc Business Overview
  4. 4.1.3 Vital Therapies Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio
  6. 4.1.5 Vital Therapies Inc Recent Developments
  7. 4.2 Verlyx Pharma Inc
  8. 4.2.1 Verlyx Pharma Inc Company Information
  9. 4.2.2 Verlyx Pharma Inc Business Overview
  10. 4.2.3 Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio
  12. 4.2.5 Verlyx Pharma Inc Recent Developments
  13. 4.3 Promethera Biosciences SA
  14. 4.3.1 Promethera Biosciences SA Company Information
  15. 4.3.2 Promethera Biosciences SA Business Overview
  16. 4.3.3 Promethera Biosciences SA Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio
  18. 4.3.5 Promethera Biosciences SA Recent Developments
  19. 4.4 Intercept Pharmaceuticals Inc
  20. 4.4.1 Intercept Pharmaceuticals Inc Company Information
  21. 4.4.2 Intercept Pharmaceuticals Inc Business Overview
  22. 4.4.3 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio
  24. 4.4.5 Intercept Pharmaceuticals Inc Recent Developments
  25. 4.5 Immuron Ltd
  26. 4.5.1 Immuron Ltd Company Information
  27. 4.5.2 Immuron Ltd Business Overview
  28. 4.5.3 Immuron Ltd Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio
  30. 4.5.5 Immuron Ltd Recent Developments
  31. 4.6 GRI Bio Inc
  32. 4.6.1 GRI Bio Inc Company Information
  33. 4.6.2 GRI Bio Inc Business Overview
  34. 4.6.3 GRI Bio Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio
  36. 4.6.5 GRI Bio Inc Recent Developments
  37. 4.7 Gilead Sciences Inc
  38. 4.7.1 Gilead Sciences Inc Company Information
  39. 4.7.2 Gilead Sciences Inc Business Overview
  40. 4.7.3 Gilead Sciences Inc Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio
  42. 4.7.5 Gilead Sciences Inc Recent Developments
  43. 4.8 Generon (Shanghai) Corp Ltd
  44. 4.8.1 Generon (Shanghai) Corp Ltd Company Information
  45. 4.8.2 Generon (Shanghai) Corp Ltd Business Overview
  46. 4.8.3 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio
  48. 4.8.5 Generon (Shanghai) Corp Ltd Recent Developments
  49. 4.9 Alfact Innovation
  50. 4.9.1 Alfact Innovation Company Information
  51. 4.9.2 Alfact Innovation Business Overview
  52. 4.9.3 Alfact Innovation Alcoholic Hepatiti Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio
  54. 4.9.5 Alfact Innovation Recent Developments
5 Global Alcoholic Hepatiti Drug Market Scenario by Region
  1. 5.1 Global Alcoholic Hepatiti Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Alcoholic Hepatiti Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Alcoholic Hepatiti Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Alcoholic Hepatiti Drug Sales by Region: 2027-2032
  5. 5.3 Global Alcoholic Hepatiti Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Alcoholic Hepatiti Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Alcoholic Hepatiti Drug Revenue by Region: 2027-2032
  8. 5.4 North America Alcoholic Hepatiti Drug Market Facts & Figures by Country
  9. 5.4.1 North America Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Alcoholic Hepatiti Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Alcoholic Hepatiti Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Alcoholic Hepatiti Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Alcoholic Hepatiti Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Alcoholic Hepatiti Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Alcoholic Hepatiti Drug Market Facts & Figures by Country
  41. 5.7.1 South America Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Alcoholic Hepatiti Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Alcoholic Hepatiti Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Alcoholic Hepatiti Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Alcoholic Hepatiti Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Alcoholic Hepatiti Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Alcoholic Hepatiti Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Alcoholic Hepatiti Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Alcoholic Hepatiti Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Alcoholic Hepatiti Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Alcoholic Hepatiti Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Alcoholic Hepatiti Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Alcoholic Hepatiti Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Alcoholic Hepatiti Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Alcoholic Hepatiti Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Alcoholic Hepatiti Drug Value Chain Analysis
  2. 8.1.1 Alcoholic Hepatiti Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Alcoholic Hepatiti Drug Production Mode & Process
  5. 8.2 Alcoholic Hepatiti Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Alcoholic Hepatiti Drug Distributors
  8. 8.2.3 Alcoholic Hepatiti Drug Customers
9 Global Alcoholic Hepatiti Drug Analyzing Market Dynamics
  1. 9.1 Alcoholic Hepatiti Drug Industry Trends
  2. 9.2 Alcoholic Hepatiti Drug Industry Drivers
  3. 9.3 Alcoholic Hepatiti Drug Industry Opportunities and Challenges
  4. 9.4 Alcoholic Hepatiti Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst